JFNIX | LHCIX | JFNIX / LHCIX | |
Total Expense Ratio | 0.77 | 0.78 | 99% |
Annual Report Gross Expense Ratio | 0.77 | 3.09 | 25% |
Fund Existence | 16 years | 6 years | - |
Gain YTD | 3.176 | 1.757 | 181% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.49B | 7.64M | 58,712% |
Annual Yield % from dividends | 0.39 | 0.56 | 70% |
Returns for 1 year | -12.39 | -2.92 | 425% |
Returns for 3 years | 21.30 | 25.21 | 84% |
Returns for 5 years | 8.34 | 3.59 | 233% |
Returns for 10 years | 39.28 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RLUEX | 12.57 | N/A | N/A |
Lazard US Equity Concentrated R6 | |||
FBDIX | 143.61 | N/A | N/A |
Franklin Biotechnology Discovery A | |||
CFSIX | 21.84 | N/A | N/A |
Touchstone Sands Capital Select Growth Y | |||
TIBRX | 31.71 | N/A | N/A |
Thornburg Investment Income Builder R3 | |||
BIRDX | 8.53 | N/A | N/A |
iShares Developed Real Estate Idx Instl |